The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey

Clinical and Experimental Rheumatology

Volumn 30, Issue 2, 2012, Pages 202-207

  Malhan, Simten ^a   Pay, Salih ^b   Ataman, Sebnem ^c   Dalkilic, Ediz ^d   Dinc, Ayhan ^b   Erken, Eren ^e   Ertenli, Ihsan ^f   Ertugrul, Esin ^g   Gogus, Feride ^h   Hamuryudan, Vedat ⁱ   Inanc, Murat ^j   Karaaslan, Yasar ^k   Karadag, Omer ^l   Karakoc, Yuksel ^m   Keskin, Goksal ⁿ   Kisacik, Bunyamin ^o   Kiraz, Sedat ^f   Oksel, Fahrettin ^p   Oksuz, Ergun ^a   Pirildar, Timur ^q   Sari, Ismail ^r   Soy, Mehmet ^s   Senturk, Taskin ^t   Taylan, Ali ^u   more..

^a BASKENT UNIVERSITY   (Turkey)

^b Gulhane Military   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

^d ULUDAG UNIVERSITY   (Turkey)

^e CUKUROVA UNIVERSITY   (Turkey)

^f HACETTEPE UNIVERSITY   (Turkey)

^g KAYSERI UNIVERSITY   (Turkey)

^h GAZI UNIVERSITY   (Turkey)

ⁱ ISTANBUL UNIVERSITY   (Turkey)

^j ISTANBUL UNIVERSITY   (Turkey)

^k ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^l Diyarbakir Training and Research Hospital   (Turkey)

^m Bursa Sevket Yilmaz Training and Research Hospital   (Turkey)

ⁿ DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^o GAZIANTEP UNIVERSITY   (Turkey)

^p EGE UNIVERSITY   (Turkey)

^q CELAL BAYAR UNIVERSITY   (Turkey)

^r UNIVERSITY OF HEALTH SCIENCES   (Turkey)

^s ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^t ADNAN MENDERES UNIVERSITY   (Turkey)

^u Izmir Tepecik Training and Research Hospital   (Turkey)

more..

Author keywords

Ankylosing spondylitis; Cost; Rheumatoid arthritis; Turkey

Indexed keywords

ANKYLOSING SPONDYLITIS; ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEATH; DISABILITY SEVERITY; DISEASE COURSE; DRUG COST; HEALTH CARE COST; HOSPITAL COST; HUMAN; MEDICAL LEAVE; MORBIDITY; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PRODUCTIVITY; RETIREMENT; RHEUMATOID ARTHRITIS; TERTIARY HEALTH CARE; TURKEY (REPUBLIC);

ABSENTEEISM; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; DISABILITY EVALUATION; HOSPITAL COSTS; HOSPITAL UNITS; HUMANS; MODELS, ECONOMIC; PROGNOSIS; RETIREMENT; RHEUMATOLOGY; SICK LEAVE; SPONDYLITIS, ANKYLOSING; TURKEY;

EID: 84863751510     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. COOPER NJ Economic burden of rheumatoid arthritis: a systematic review. Rheumatol 2000; 39: 28-33.
2. AKAR S, BIRLIK M, GURLER O et al. The prevalence of rheumatoid arthritis in an urban population of Izmir Turkey. Clin Exp Rheumatol 2004; 22: 416-20.
3. PLASQUI G The role of physical activity in rheumatoid arthritis. Physiol Behav 2008; 94: 270-5.
4. HAYWOOD KL Health outcomes in ankylosing spondylitis: An evaluation of patientbased and anthropometric measures, DPhil Thesis, University of York, York, 2000: 353
5. ONEN F, AKAR S, BIRLIK M et al. Prevalence of ankylosing spondylitis and related spondyloarthritis in an urban area of Izmir Turkey. J Rheumatol 2008; 35: 305-9.
6. CAKIR N, PAMUK ON, DERVIS E et al. The prevalence of some rheumatic disease western Turkey; Havsa Study. Rheumatol Int, 2011 DOI: 10.1007/S296-010-1699-4.
7. LUCE BR, MANNING WG Estimating costs in cost effectiveness analysis. In: GOLD MR, SIEGEL JE, RUSSELL L, WEISTEIN MC (Eds.): Cost Effectiveness in Health and Medicine. New York Oxford University Press, 1996: 176-213.
8. COWLEY P, BODABILLA L, MUSGROVE P, SAXENIAN H Content and financing of an essential national package of health services, Global assessments in the health sector. World Health Organisation 1994: 171-81.
9. TURKISH REPUBLIC, MINISTRY OF LABOUR AND SOCIAL SECURITY. www.calisma.gov.tr.
10. FAUTREL B, GUILLEMIN F Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 2002; 14: 121-6.
11. GUILLEMIN F, DURIEUX S, DAURES JP et al. Costs of Rheumatoid Arthritis in France: A multicenter study of 1109 patients managed by hospital based rheumatologists. J Rheumatol 2004; 31: 1297-304.
12. VERSTAPPEN SM, VERKLEIJ H, BIJLSMA JW et al. Determinants of direct costs in Dutch rheumatoid arthritis patients. Ann Rheum Dis 2004; 63: 817-24.
13. WESTHOVENS R, BOONEN A, VERBRUGGEN L et al. Healthcare consumption and direct costs of rheumatoid arthritis in Belgium. Clin Rheumatol 2005; 24: 615-9.
14. HÜLSEMANN JL, RUOF J, ZEIDLER H, MITTENDORF T Costs in rheumatology: results and lessons learned from Hannover Costing Study. Rheumatol Int 2006; 26: 704-11.
15. PÉNTEK M, KOBELT G, CZIRJÁK L et al. Costs of rheumatoid arthritis in Hungary. J Rheumatol 2006; 33: 2124-31.
16. SOKKA T, ABELSON B, PINCUS T Mortality in Rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26: 35-61.
17. MERKESDAL S, HUELSEMANN JL, MITTENDORF T, ZEH S, ZEIDLER H, RUOF J Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components. Rheumatol 2006; 65: 527-34.
18. ARA MR, PACKHAM JC, HAYWOOD KL The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Rheumatol 2008; 47: 68-71.
19. BOONEN A, VAN DER HEIJDE D, LANDEWÉ R et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 2002; 61: 429-37.
20. KOBELT G, SOBOCKI P, MULERO P, GRATACOS J, POCOVI A, ESTEVEZ E The burden of Ankylosing Spondylitis in Spain. Value Health 2008; 11: 408-15.
21. WARD MM Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 2002; 46: 223-31.
22. KOBELT G, ANDLIN-SOBOCKI P, ROUSSEAU C, MAKSYMOWYCH W Cost and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 2006; 33: 289-95.
23. RINGSDAL VS, HELIN P Ankylosing Spondylitis-education, employment and invalidity. Dan Med Bull 1991; 38: 282-4.
24. NISSILA M, ISOMAKI HA, KAARELA K, KIVINIEMI P, MARTIO J, SARNA S Prognosis of inflammatory joint disease. A three year follow-up study. Scand J Rheumatol 1983; 12: 33-8.
25. ZINK A, BRAUN J, LISTING J, WOLLENHAUPT J Disability and handicap in rheumatoid arthritis and ankylosing spondylitis. Results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000; 27: 613-22.
26. LEHTINEN K Working ability of 76 patients with ankylosing spondylitis. Scand J Rheumatol 1981; 10: 263-5.
27. BOONEN A, CHORUS A, MIEDEMA H, VAN DER HEIJDE D, VAN DER TEMPEL H, VAN DER LINDEN S Employment, work disability and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 2001; 60: 353-8.
28. MCGUIGAN LE, HART HH, GOW PJ, KIDD BL, GRIGOR RR, MOORE TE Employment in ankylosing spondylitis. Ann Rheum Dis 1984; 43: 604-6.
29. GRAN JT, SKOMSVOLL JF The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997; 36: 766-71.
30. CHAMBERLAIN MA Socioeconomic effects of ankylosing spondylitis. Int Rehabil Med 1981; 3: 94-9.
31. WARD M, KUZIS S Risk factors for work disability in patients with ankylosing spondylitis. J Rheumatol 2001; 28: 315-21.
32. FRANKE LC, AMENT AJHA, LAAR MAFJ, BOONEN A, SEVERENS JL Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009; 27 (Suppl. 55): S118-S123.
33. MINISTRY OF HEALTH, TURKISH HEALTH ORGANIZATION, NATIONAL BURDEN OF DISEASE REPORT, 2005
34. BOONEN A, MAU W: The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009; 27 (Suppl. 55): S112-7.